The phase of no hope is over

For forty years, pancreatic cancer barely moved. The science was stuck. Survival hardly budged. That has just changed.

In 2026, a new drug did something this disease had never allowed before - it roughly doubled survival in a major trial by hitting a genetic target long dismissed as "undruggable." The results earned a standing ovation at the world's largest cancer conference. It isn't a cure, and it isn't the finish line. But it is proof of something many have waited decades to say: this disease can be beaten back.

The era of "nothing works" is ending. A new phase has begun - but this kind of progress isn't inevitable. It moves faster the more brilliant minds we can put to work on it. That's exactly what your gift does: it puts another exceptional Australian researcher into this fight, at the moment the science is finally moving.

Prof Marina Pajic & Dare to Hope Fellow Dr Matteo Golo - Garvan Institure

Time left for giving